Efficacy and safety of long-term adefovir dipivoxil therapy in children with chronic hepatitis B infection.

Jonas, Maureen M;Kelly, Deirdre;Pollack, Henry;Mizerski, Jacek;Sokal, Etienne;et.al.
(2012) The Pediatric infectious disease journal —

Files

No attached file found for this publication.

Details

Authors
  • Jonas, Maureen M
    Author
  • Kelly, Deirdre
    Author
  • Pollack, Henry
    Author
  • Mizerski, Jacek
    Author
  • Sokal, EtienneUCLouvain
    Author
Show more
Abstract
Prolonged ADV treatment is safe in children. If reserved only for those with virologic response within 6 months, viral resistance was minimal.
Affiliations

Citations

  • APA
  • Chicago
  • FWB

Jonas, M. M., Kelly, D., Pollack, H., Mizerski, J., Sorbel, J., Frederick, D., Mondou, E., Rousseau, F., & Sokal, E. (2012). Efficacy and safety of long-term adefovir dipivoxil therapy in children with chronic hepatitis B infection. The Pediatric infectious disease journal. https://doi.org/10.1097/INF.0b013e318255ffe7